Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny Inc.

Progyny ( ($PGNY) ) just unveiled an update. Progyny, Inc. announced that its board has authorized a share repurchase program of up to $200 million...

Progyny Announces $200 Million Share Repurchase Authorization

Progyny received a Buy rating and a $30.00 price target from Goldman Sachs analyst today. In addition to Goldman Sachs, Progyny also received a Buy...

Positive Report for Progyny (PGNY) from Goldman Sachs

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Owlet (OWLT), Concentra Group Holdings Parent, Inc. ...

Analysts Offer Insights on Healthcare Companies: Owlet (OWLT), Concentra Group Holdings Parent, Inc. (CON) and Progyny (PGNY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Caribou Biosciences (CRBU), Progyny (PGNY) and Evole...

Analysts’ Top Healthcare Picks: Caribou Biosciences (CRBU), Progyny (PGNY)

Progyny ( ($PGNY) ) has provided an update. Progyny reported record first‑quarter 2026 revenue of $328.5 million on May 7, 2026, with growth in bot...

Progyny Delivers Record Q1 2026 Revenue and Growth

Hartshead Resources NL ( ($AU:HHR) ) has provided an update. Hartshead Resources has mailed and emailed its scheme booklet to shareholders detailin...

Hartshead Board Backs ACAM Cash Takeover as Scheme Booklet Lands With Shareholders

Hartshead Resources NL ( ($AU:HHR) ) has shared an update. Hartshead Resources has confirmed that its scheme booklet for the proposed acquisition o...

Current Quarter	$0.3	Next Quarter	$0.29
Current Year	$1.12	Next Year	$1.32
QoQ Growth	-3.3%	YoY Growth	+17.9%
3Y EPS CAGR	+27.3%	Target Price	$29.55
Consensus	Buy	Upside	+18.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PGNY	$25.05	+0.68%	1.10M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PGNY	$25.05	+0.7%	1.10M
3
4
5
6

PGNY

PGNY

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Progyny Inc. Data in Excel

Get Progyny Inc. Data in Excel